Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Idexx Laboratories Inc (IDXX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014358
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, microbiological contaminant testing products (in water), livestock and poultry diagnostic and health-monitoring products, antibiotic residue testing products (in milk), and practice management systems and services. IDEXX also sells a line of portable electrolytes and blood gas analyzers for the human point-of-care medical diagnostics market. The company offers its products to veterinary, equine, livestock and poultry, water testing and dairy markets. It operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. IDEXX is headquartered in Westbrook, Maine, the US.

Idexx Laboratories Inc (IDXX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Idexx Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Idexx Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Idexx Labs Enters Into Licensing Agreement With Exiqon For Locked Nucleic Acids Technology 10
Debt Offering 11
Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million 11
Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million 12
Idexx Laboratories Inc – Key Competitors 13
Idexx Laboratories Inc – Key Employees 14
Idexx Laboratories Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 18
Financial Announcements 18
Oct 31, 2017: IDEXX Laboratories Announces Third Quarter Results 18
Apr 28, 2017: IDEXX Laboratories Announces First Quarter Results-2017 20
Apr 29, 2016: IDEXX Laboratories Announces First Quarter Results 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Idexx Laboratories Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Idexx Laboratories Inc, Medical Devices Deals, 2011 to YTD 2017 8
Idexx Laboratories Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Idexx Labs Enters Into Licensing Agreement With Exiqon For Locked Nucleic Acids Technology 10
Idexx Labs Completes Private Placement Of Series B Notes Due 2025 For US$75 Million 11
Idexx Labs Completes Private Placement Of Series A Notes Due 2023 For US$75 Million 12
Idexx Laboratories Inc, Key Competitors 13
Idexx Laboratories Inc, Key Employees 14
Idexx Laboratories Inc, Other Locations 15
Idexx Laboratories Inc, Subsidiaries 15

★海外企業調査レポート[Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lion Energy Ltd (LIO):企業の財務・戦略的SWOT分析
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Spark Infrastructure Group:発電所・企業SWOT分析
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Jungheinrich AG:企業の戦略・SWOT・財務情報
    Jungheinrich AG - Strategy, SWOT and Corporate Finance Report Summary Jungheinrich AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lenzing AG (LNZ):企業の財務・戦略的SWOT分析
    Lenzing AG (LNZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Norgine BV:企業の戦略的SWOT分析
    Norgine BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Lite-On Technology Corp (2301):企業の財務・戦略的SWOT分析
    Lite-On Technology Corp (2301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Polpharma SA:企業の戦略的SWOT分析
    Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • NII Holdings, Inc.:戦略・SWOT・企業財務分析
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Daegu Bank Ltd:企業の戦略・SWOT・財務分析
    Daegu Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Daegu Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Rum Group for Transportation & Tourism Investment:企業の戦略・SWOT・財務情報
    Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report Summary Rum Group for Transportation & Tourism Investment - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • Harting AG & Co KG:企業の戦略的SWOT分析
    Harting AG & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Grafton Group Plc:企業の戦略・SWOT・財務情報
    Grafton Group Plc - Strategy, SWOT and Corporate Finance Report Summary Grafton Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tenneco Inc (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Oleo e Gas Participacoes SA (OGXP3):企業の財務・戦略的SWOT分析
    Summary Oleo e Gas Participacoes SA (OGX) is an oil and gas company that acquires and explores for oil and natural gas properties. The company operates a diversified portfolio of exploratory blocks located in offshore sedimentary basins in Brazil. It operates blocks located in onshore sedimentary ba …
  • Redbiotec AG-製薬・医療分野:企業M&A・提携分析
    Summary Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing prod …
  • ABB Ltd (ABBN):電力:M&Aディール及び事業提携情報
    Summary ABB Ltd (ABB) is a provider of industrial technologies. It offers products, systems, solutions, and services in electrification products, motion, industrial automation, industrial automation, and power grids. The company’s offerings harness power reliability, increase industrial productivity …
  • Mead Johnson Nutrition Company:企業の戦略・SWOT・財務情報
    Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report Summary Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Novartis Pharmaceuticals Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Novartis Pharmaceuticals Corp (Novartis), a subsidiary of Novartis AG, is a manufacturer of prescription drugs. The company portfolio includes cardio metabolic, ophthalmology, respiratory, neuroscience, immunology and dermatology, oncology, call and gene therapy. It provides medicines such a …
  • Capital Power Corporation (CPX):電力:M&Aディール及び事業提携情報
    Summary Capital Power Corporation (CPC) is a power producer that develops, acquires, operates, optimizes, and builds power generation facilities. It generates electricity by harnessing energy-efficient technology from lower-carbon fuel, and a range of renewable energy sources. The company owns super …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆